Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saffron as adjuvant therapy for chronic schizophrenia
IRCT20090117001556N140Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of saffron in schizophrenia, sponsored by Tehran University of Medical Sciences. Started Dec 2021; status: completed.
02
Drugs
saffron
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20090117001556N140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090117001556N140.